BDX SEC filings (2026)
CIK 10795 · Surgical & Medical Instruments & Apparatus (SIC 3841) · incorporated in NJ · fiscal year ends in September
3,060 filings on EDGAR since 1994 · 35 annual, 100 quarterly, 427 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
August 2026
- Aug 26Insider saleFeld Michael (EVP, Chief Revenue Officer) sold 165 shares for $31K at $188.49 under a 10b5-1 plan
- Aug 13Insider salePolen Thomas E Jr (Chairman, CEO and President · Director) sold 4,152 shares for $768K at $185.00 under a 10b5-1 plan
- Aug 11Insider saleGoette Roland (EVP and President, EMEA) sold 2,438 shares for $441K at $180.84
- Aug 6EarningsEarnings release — EPS $3.23 vs $3.14 est. (+2.9%); revenue $4.98B (+5% y/y) 3.8%
- Aug 6ReportQuarterly report, Q3 2026 — revenue $4.98B (+5% y/y), net income $377.0M, EPS $1.37
July 2026
- Jul 27Insider saleFeld Michael (EVP, Chief Revenue Officer) sold 75 shares for $12K at $157.13 under a 10b5-1 plan
- Jul 228-K8-K · Mike Garrison to Retire from BDDirectors or officers; compensation; Regulation FD disclosure
June 2026
- Jun 26Insider saleFeld Michael (EVP, Chief Revenue Officer) sold 75 shares for $11K at $152.80 under a 10b5-1 plan
- Jun 24Insider saleGarrison Michael David (EVP & Pres Med.Essntl&BioPharm) sold 1,100 shares for $160K at $145.66 under a 10b5-1 plan
- Jun 10Insider saleGarrison Michael David (EVP & Pres Med.Essntl&BioPharm) sold 1,100 shares for $167K at $151.48 under a 10b5-1 plan
- Jun 1Insider salePolen Thomas E Jr (Chairman, CEO and President · Director) sold 2,764 shares for $405K at $146.35 under a 10b5-1 plan
May 2026
- May 298-K8-K · Regulation FD disclosure
- May 26Insider saleFeld Michael (EVP, Chief Revenue Officer) sold 75 shares for $11K at $147.35 under a 10b5-1 plan
- May 208-K8-K · Material definitive agreement; New financial obligation
- May 128-K8-K · Other events
- May 7EarningsEarnings release — EPS $2.90 vs $2.77 est. (+4.7%); revenue $4.71B (+5% y/y) 5.9%
- May 7ReportQuarterly report, Q2 2026 — revenue $4.71B (+5% y/y), net income −$311.0M, EPS −$1.11
- May 78-K8-K · Directors or officers; compensation; Regulation FD disclosure
April 2026
- Apr 298-K8-K · Charter, bylaws or fiscal-year change
- Apr 27Insider saleFeld Michael (EVP, Chief Revenue Officer) sold 74 shares for $11K at $151.94 under a 10b5-1 plan
- Apr 98-K8-K · Rick Byrd to Retire from BDDirectors or officers; compensation; Regulation FD disclosure
- Apr 28-K8-K · Results of operations
March 2026
February 2026
- Feb 26Insider saleFeld Michael (EVP, Chief Revenue Officer) sold 75 shares for $14K at $181.84 under a 10b5-1 plan
- Feb 258-K8-K · Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer CapOther events
- Feb 18Insider saleSCOTT BERTRAM L (Director) sold 953 shares for $174K at $182.61
- Feb 108-K8-K · Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt SecuritiesOther events
- Feb 9EarningsEarnings release — EPS $2.91 vs $2.82 est. (+3.2%); revenue $5.25B (+2% y/y) 1.3%
- Feb 9ReportQuarterly report, Q1 FY2026 — revenue $5.25B (+2% y/y), net income $382.0M, EPS $1.34
- Feb 98-K8-K · BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters CorporationMaterial definitive agreement; Directors or officers; compensation; Regulation FD disclosure; Other events
- Feb 58-K8-K · Unregistered sale of equity; Charter, bylaws or fiscal-year change
- Feb 58-K8-K · Regulation FD disclosure
January 2026
- Jan 308-K8-K · Directors or officers; compensation; Shareholder vote results
- Jan 26Insider saleFeld Michael (EVP, CRO & Pres. Life Sciences) sold 75 shares for $15K at $202.73 under a 10b5-1 plan
- Jan 15Insider saleGarrison Michael David (EVP & Pres Med.Essntl&BioPharm) sold 1,610 shares for $334K at $206.54–$209.00 under a 10b5-1 plan
- Jan 68-K8-K · Item 5.04
December 2025
- Dec 18ProxyProxy · Annual report to shareholders
- Dec 18ProxyProxy · Additional proxy materials
- Dec 18ProxyProxy · Proxy statement
- Dec 18-K8-K · Directors or officers; compensation
November 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $2.6M in 16 sales and bought nothing on the open market; 39 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 28, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerSold · $14K · 76 sh · 10b5-1 |
| Aug 26, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerSold · $31K · 165 sh · 10b5-1 |
| Aug 13, 2026Form 4 | Polen Thomas E JrChairman, CEO and President · DirectorSold · $768K · 4,152 sh · 10b5-1 |
| Aug 11, 2026Form 4 | Goette RolandEVP and President, EMEASold · $441K · 2,438 sh |
| Jul 27, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerSold · $12K · 75 sh · 10b5-1 |
| Jun 26, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerSold · $11K · 75 sh · 10b5-1 |
| Jun 24, 2026Form 4 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmSold · $160K · 1,100 sh · 10b5-1 |
| Jun 10, 2026Form 4 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmSold · $167K · 1,100 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Polen Thomas E JrChairman, CEO and President · DirectorSold · $405K · 2,764 sh · 10b5-1 |
| May 26, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerSold · $11K · 75 sh · 10b5-1 |
| Apr 27, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerSold · $11K · 74 sh · 10b5-1 |
| Mar 26, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerSold · $12K · 75 sh · 10b5-1 |
| Feb 26, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerSold · $14K · 75 sh · 10b5-1 |
| Feb 18, 2026Form 4 | SCOTT BERTRAM LDirectorSold · $174K · 953 sh |
| Jan 26, 2026Form 4 | Feld MichaelEVP, CRO & Pres. Life SciencesSold · $15K · 75 sh · 10b5-1 |
| Jan 15, 2026Form 4 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmSold · $334K · 1,610 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 39 transactions
| Date | Insider |
|---|---|
| Sep 2, 2026Form 4 | Roque VitorEVP & Chief Financial OfficerTax withholding · $0 · 190 sh |
| Aug 20, 2026Form 4 | Feld MichaelEVP, Chief Revenue OfficerTax withholding · $0 · 1,049 sh |
| Aug 13, 2026Form 4 | Polen Thomas E JrChairman, CEO and President · DirectorOther · $7.2M · 39,126 sh · 10b5-1 |
| Aug 13, 2026Form 4 | Polen Thomas E JrChairman, CEO and President · DirectorExercise or conversion · $7.2M · 43,278 sh · 10b5-1 |
| Aug 13, 2026Form 4 | Polen Thomas E JrChairman, CEO and President · DirectorExercise or conversion · $0 · 43,278 sh · 10b5-1 |
| Aug 6, 2026Form 4 | Huffines Robert LutherDirectorAward · $31K · 189 sh |
| Aug 6, 2026Form 4 | Byington Carrie LDirectorAward · $16K · 94 sh |
| Jul 2, 2026Form 4 | Muhsin BilalEVP & President Connected CareTax withholding · $0 · 1,935 sh |
| Jul 1, 2026Form 4 | Muhsin BilalEVP & President Connected CareAward · $0 · 14,342 sh |
| Jun 1, 2026Form 4 | Polen Thomas E JrChairman, CEO and President · DirectorOther · $2.5M · 17,445 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Polen Thomas E JrChairman, CEO and President · DirectorExercise or conversion · $2.5M · 20,209 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Polen Thomas E JrChairman, CEO and President · DirectorExercise or conversion · $0 · 20,209 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Menziuso PeterEVP and President, BDIAward · $0 · 14,258 sh |
| May 8, 2026Form 4 | Huffines Robert LutherDirectorAward · $31K · 210 sh |
| May 8, 2026Form 4 | Byington Carrie LDirectorAward · $16K · 105 sh |
| May 7, 2026Form 4 | Roque VitorEVP & Chief Financial OfficerAward · $0 · 1,721 sh |
| Apr 6, 2026Form 4 | Neal Shana CarolEVP and Chief People OfficerTax withholding · $0 · 1,146 sh |
| Mar 16, 2026Form 4 | Minnix LaneshaEVP and General CounselAward · $0 · 7,492 sh |
| Mar 2, 2026Form 4 | Spikner Pamela L.SVP Controller & CAOAward · $0 · 931 sh |
| Mar 2, 2026Form 4 | Roque VitorInterim CFOAward · $0 · 931 sh |
| Feb 4, 2026Form 4 | Jones Christopher Ian MontagueDirectorAward · $55K · 272 sh |
| Feb 4, 2026Form 4 | Huffines Robert LutherDirectorAward · $20K · 100 sh |
| Feb 4, 2026Form 4 | Byington Carrie LDirectorAward · $6,057 · 30 sh |
| Jan 27, 2026Form 4 | Wright JacquelineDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | Waldstreicher JoanneDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | SCOTT BERTRAM LDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | RING TIMOTHY MDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | Jones Christopher Ian MontagueDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | Huffines Robert LutherDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | Brown William MDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | HAYES GREGORYDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | Byington Carrie LDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | ECKERT R ANDREWDirectorAward · $0 · 1,098 sh |
| Jan 27, 2026Form 4 | Henderson Jeffrey WilliamDirectorAward · $0 · 1,098 sh |
| Jan 21, 2026Form 4 | Spikner Pamela L.SVP Controller & CAOTax withholding · $0 · 84 sh |
| Jan 15, 2026Form 4 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmOther · $513K · 2,454 sh · 10b5-1 |
| Jan 15, 2026Form 4 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmExercise or conversion · $513K · 3,054 sh · 10b5-1 |
| Jan 15, 2026Form 4 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmExercise or conversion · $0 · 3,054 sh · 10b5-1 |
| Jan 3, 2026Form 4 | Shan DavidEVP and Chief ISC OfficerTax withholding · $0 · 44 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 21 filings
| Filed | What it is |
|---|---|
| Aug 6, 202610-Q | Quarterly report, Q3 2026 — revenue $4.98B (+5% y/y), net income $377.0M, EPS $1.37 |
| Aug 6, 20268-K | Earnings release — EPS $3.23 vs $3.14 est. (+2.9%); revenue $4.98B (+5% y/y) 3.8% |
| Jul 22, 20268-K | Mike Garrison to Retire from BDDirectors or officers; compensation; Regulation FD disclosure |
| May 29, 20268-K | Regulation FD disclosure |
| May 20, 20268-K | Material definitive agreement; New financial obligation |
| May 12, 20268-K | Other events |
| May 7, 202610-Q | Quarterly report, Q2 2026 — revenue $4.71B (+5% y/y), net income −$311.0M, EPS −$1.11 |
| May 7, 20268-K/A | Directors or officers; compensation; Regulation FD disclosure |
| May 7, 20268-K | Earnings release — EPS $2.90 vs $2.77 est. (+4.7%); revenue $4.71B (+5% y/y) 5.9% |
| Apr 29, 20268-K | Charter, bylaws or fiscal-year change |
| Apr 9, 20268-K | Rick Byrd to Retire from BDDirectors or officers; compensation; Regulation FD disclosure |
| Apr 2, 20268-K | Results of operations |
| Feb 25, 20268-K | Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer CapOther events |
| Feb 10, 20268-K | Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt SecuritiesOther events |
| Feb 9, 202610-Q | Quarterly report, Q1 FY2026 — revenue $5.25B (+2% y/y), net income $382.0M, EPS $1.34 |
| Feb 9, 20268-K | BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters CorporationMaterial definitive agreement; Directors or officers; compensation; Regulation FD disclosure; Other events |
| Feb 9, 20268-K | Earnings release — EPS $2.91 vs $2.82 est. (+3.2%); revenue $5.25B (+2% y/y) 1.3% |
| Feb 5, 20268-K | Unregistered sale of equity; Charter, bylaws or fiscal-year change |
| Feb 5, 20268-K | Regulation FD disclosure |
| Jan 30, 20268-K | Directors or officers; compensation; Shareholder vote results |
| Jan 6, 20268-K | Item 5.04 |
2025 · 22 filings
| Filed | What it is |
|---|---|
| Dec 18, 2025ARS | Annual report to shareholders |
| Dec 18, 2025DEFA14A | Additional proxy materials |
| Dec 18, 2025DEF 14A | Proxy statement |
| Dec 1, 20258-K/A | Directors or officers; compensation |
| Nov 25, 202510-K | Annual report, FY2025 — revenue $21.84B (+8% y/y), net income $1.68B, EPS $5.82 |
| Nov 17, 20258-K | Directors or officers; compensation |
| Nov 6, 20258-K | Earnings release — EPS $3.96 vs $3.92 est. (+1.0%); revenue $8.30B (+53% y/y) 0.6% |
| Oct 15, 20258-K | Results of operations; Directors or officers; compensation; Regulation FD disclosure |
| Sep 18, 20258-K | Material definitive agreement; New financial obligation |
| Aug 7, 202510-Q | Quarterly report, Q3 2025 — revenue $4.73B (−5% y/y), net income $574.0M, EPS $2.00 |
| Aug 7, 20258-K | Earnings release — EPS $3.68 vs $3.42 est. (+7.6%); revenue $4.73B (−5% y/y) 8.9% |
| Jul 14, 20258-K | Material definitive agreement |
| Jul 14, 20258-K | Regulation FD disclosure |
| Jun 16, 20258-K | Regulation FD disclosure |
| May 2, 20258-K | Charter, bylaws or fiscal-year change |
| May 1, 202510-Q | Quarterly report, Q2 2025 — revenue $4.48B (−11% y/y), net income $308.0M, EPS $1.07 |
| May 1, 20258-K | Earnings release — EPS $3.35 vs $3.28 est. (+2.1%); revenue $4.48B (−11% y/y) 18.1% |
| Mar 27, 20258-K | Directors or officers; compensation |
| Feb 6, 202510-Q | Quarterly report, Q1 FY2025 — revenue $5.17B (+10% y/y), net income $303.0M, EPS $1.04 |
| Feb 5, 20258-K | Earnings release — EPS $3.43 vs $2.98 est. (+15.1%); revenue $5.17B (+10% y/y) 7.3% |
| Jan 31, 20258-K | Shareholder vote results |
| Jan 10, 20258-K | Directors or officers; compensation; Regulation FD disclosure |
2024 · 20 filings
| Filed | What it is |
|---|---|
| Dec 19, 2024ARS | Annual report to shareholders |
| Dec 19, 2024DEFA14A | Additional proxy materials |
| Dec 19, 2024DEF 14A | Proxy statement |
| Nov 27, 202410-K | Annual report, FY2024 — revenue $20.18B (+4% y/y), net income $1.71B, EPS $5.86 |
| Nov 7, 20248-K | Results of operations |
| Oct 2, 20248-K | Regulation FD disclosure |
| Aug 30, 20248-K | Directors or officers; compensation |
| Aug 1, 202410-Q | Quarterly report, Q3 2024 — revenue $4.99B (+2% y/y), net income $487.0M, EPS $1.68 |
| Aug 1, 20248-K | Earnings release — EPS $3.50 vs $3.31 est. (+5.7%); revenue $4.99B (+2% y/y) 2.1% |
| Jul 12, 20248-K | Material definitive agreement; New financial obligation |
| Jun 7, 20248-K | Material definitive agreement; New financial obligation |
| Jun 3, 20248-K | Regulation FD disclosure |
| May 2, 202410-Q | Quarterly report, Q2 2024 — revenue $5.04B (+5% y/y), net income $537.0M, EPS $1.85 |
| May 2, 20248-K | Earnings release — EPS $3.17 vs $2.96 est. (+7.1%); revenue $5.04B (+5% y/y) 2.8% |
| Feb 27, 20248-K | Directors or officers; compensation; Regulation FD disclosure |
| Feb 8, 20248-K | New financial obligation |
| Feb 6, 20248-K | Other events |
| Feb 1, 202410-Q | Quarterly report, Q1 FY2024 — revenue $4.71B (+3% y/y), net income $281.0M, EPS $0.96 |
| Feb 1, 20248-K | Earnings release — EPS $2.68 vs $2.39 est. (+12.1%); revenue $4.71B (+3% y/y) 1.5% |
| Jan 26, 20248-K | Shareholder vote results |
2023 · 22 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Dec 14, 2023ARS | Annual report to shareholders |
| Dec 14, 2023DEFA14A | Additional proxy materials |
| Dec 14, 2023DEF 14A | Proxy statement |
| Nov 21, 202310-K | Annual report, FY2023 — revenue $19.37B (+3% y/y), net income $1.48B, EPS $4.94 |
| Aug 3, 202310-Q | Quarterly report, Q3 2023 — revenue $4.88B (+5% y/y), net income $407.0M, EPS $1.36 |
| May 4, 202310-Q | Quarterly report, Q2 2023 — revenue $4.82B (+1% y/y), net income $460.0M, EPS $1.53 |
| Feb 2, 202310-Q | Quarterly report, Q1 FY2023 — revenue $4.59B (−3% y/y), net income $509.0M, EPS $1.70 |
15 current reports (8-K) not listed; the year is on EDGAR.
2022 · 28 filings — 19 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Dec 15, 2022DEFA14A | Additional proxy materials |
| Dec 15, 2022DEF 14A | Proxy statement |
| Nov 22, 202210-K | Annual report, FY2022 — revenue $18.87B (−1% y/y), net income $1.78B, EPS $5.88 |
| Aug 4, 202210-Q | Quarterly report, Q3 2022 — revenue $4.64B (+1% y/y), net income $360.0M, EPS $1.18 |
| May 5, 202210-Q | Quarterly report, Q2 2022 — revenue $4.75B (−3% y/y), net income $454.0M, EPS $1.50 |
| Feb 3, 202210-Q | Quarterly report, Q1 FY2022 — revenue $4.72B (−11% y/y), net income $677.0M, EPS $2.28 |
| Jan 6, 2022DEFA14A | Additional proxy materials |
| Jan 6, 2022DEFA14A | Additional proxy materials |
| Jan 5, 2022PX14A6G | Shareholder exempt solicitation |
19 current reports (8-K) not listed; the year is on EDGAR.
2021 · 28 filings — 20 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Dec 16, 2021DEFA14A | Additional proxy materials |
| Dec 16, 2021DEF 14A | Proxy statement |
| Nov 24, 202110-K | Annual report, FY2021 — revenue $19.13B (+19% y/y), net income $2.09B, EPS $6.85 |
| Aug 5, 202110-Q | Quarterly report, Q3 2021 — revenue $4.61B (+20% y/y), net income $525.0M, EPS $1.72 |
| May 6, 202110-Q | Quarterly report, Q2 2021 — revenue $4.91B (+15% y/y), net income $299.0M, EPS $0.94 |
| Feb 4, 202110-Q | Quarterly report, Q1 FY2021 — revenue $5.32B (+26% y/y), net income $1.00B, EPS $3.35 |
| Jan 19, 2021DEFA14A | Additional proxy materials |
21 current reports (8-K) not listed; the year is on EDGAR.
2020 · 21 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Dec 17, 2020DEFA14A | Additional proxy materials |
| Dec 17, 2020DEF 14A | Proxy statement |
| Nov 25, 202010-K | Annual report, FY2020 — revenue $16.07B (−7% y/y), net income $874.0M, EPS $2.71 |
| Aug 6, 202010-Q | Quarterly report, Q3 2020 — revenue $3.85B (−11% y/y), net income $286.0M, EPS $0.97 |
| May 7, 202010-Q | Quarterly report, Q2 2020 — revenue $4.25B (+1% y/y), net income $183.0M, EPS $0.53 |
| Feb 6, 202010-Q | Quarterly report, Q1 FY2020 — revenue $4.22B (+2% y/y), net income $278.0M, EPS $0.87 |
15 current reports (8-K) not listed; the year is on EDGAR.
2019 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Dec 16, 2019DEFA14A | Additional proxy materials |
| Dec 16, 2019DEFR14A | Proxy statements |
| Nov 27, 201910-K | Annual report, FY2019 — revenue $17.29B (+8% y/y), net income $1.23B, EPS $3.94 |
| Aug 6, 201910-Q | Quarterly report, Q3 2019 — revenue $4.35B (+2% y/y), net income $451.0M, EPS $1.51 |
| May 9, 201910-Q | Quarterly report, Q2 2019 — revenue $4.20B (−1% y/y), net income $20.0M, EPS −$0.07 |
| Feb 5, 201910-Q | Quarterly report, Q1 FY2019 — revenue $4.16B (+35% y/y), net income $599.0M, EPS $2.05 |
12 current reports (8-K) not listed; the year is on EDGAR.
2018 · 24 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
| Filed | What it is |
|---|---|
| Dec 13, 2018DEFA14A | Additional proxy materials |
| Dec 13, 2018DEFR14A | Proxy statements |
| Dec 3, 2018DEF 14A | Proxy statement |
| Nov 21, 201810-K | Annual report, FY2018 — revenue $15.98B (+32% y/y), net income $311.0M, EPS $0.60 |
| Aug 2, 201810-Q | Quarterly report, Q3 2018 — revenue $4.28B (+41% y/y), net income $594.0M, EPS $2.03 |
| May 3, 201810-Q | Quarterly report, Q2 2018 — revenue $4.22B (+42% y/y), net income −$12.0M, EPS −$0.19 |
| Feb 6, 201810-Q | Quarterly report, Q1 FY2018 — revenue $3.08B (+5% y/y), net income −$136.0M, EPS −$0.76 |
17 current reports (8-K) not listed; the year is on EDGAR.
2017 · 23 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Dec 14, 2017DEFA14A | Additional proxy materials |
| Dec 14, 2017DEF 14A | Proxy statement |
| Nov 22, 201710-K | Annual report, FY2017 — revenue $12.09B (−3% y/y), net income $1.10B, EPS $4.60 |
| Aug 3, 201710-Q | Quarterly report, Q3 2017 — revenue $3.04B (−5% y/y), net income −$132.0M, EPS −$0.75 |
| May 2, 201710-Q | Quarterly report, Q2 2017 — revenue $2.97B (−3% y/y), net income $344.0M, EPS $1.58 |
| Feb 2, 201710-Q | Quarterly report, Q1 FY2017 — revenue $2.92B (−2% y/y), net income $562.0M, EPS $2.58 |
17 current reports (8-K) not listed; the year is on EDGAR.
2016 · 19 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 22 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2014 · 23 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2013 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2012 · 21 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2011 · 17 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2010 · 17 filings — 8 × 8-K, 3 × 10-Q, 2 × 10-K/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2009 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2008 · 19 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2007 · 18 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2006 · 23 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2005 · 18 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2004 · 24 filings — 18 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2003 · 30 filings — 23 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2002 · 25 filings — 18 × 8-K, 3 × 10-Q, 2 × DEF 14A and 2 other forms
Counted, not listed; the year is on EDGAR.
2001 · 17 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2000 · 22 filings — 12 × 8-K, 5 × 8-K/A, 3 × 10-Q and 2 other forms
Counted, not listed; the year is on EDGAR.
1999 · 19 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1998 · 13 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
1997 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 1 other form
Counted, not listed; the year is on EDGAR.
1996 · 7 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K405 and 1 other form
Counted, not listed; the year is on EDGAR.
1995 · 8 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
1994 · 7 filings — 3 × 10-Q, 2 × DEF 14A, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 89 filings — 46 × 4, 21 × 144, 4 × 3 and 10 other forms
| Filed | What it is |
|---|---|
| Sep 29, 20264 | Insider transaction (Form 4) |
| Sep 28, 2026144 | Notice of proposed sale (Form 144) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Aug 27, 20264 | Insider transaction (Form 4) |
| Aug 26, 2026144 | Notice of proposed sale (Form 144) |
| Aug 24, 20264 | Insider transaction (Form 4) |
| Aug 20, 2026144 | Notice of proposed sale (Form 144) |
| Aug 14, 20264 | Insider transaction (Form 4) |
| Aug 13, 2026144 | Notice of proposed sale (Form 144) |
| Aug 12, 20264 | Insider transaction (Form 4) |
| Aug 11, 2026144 | Notice of proposed sale (Form 144) |
| Aug 7, 2026SCHEDULE 13G | Other filings |
| Aug 6, 20264 | Insider transaction (Form 4) |
| Aug 6, 20264 | Insider transaction (Form 4) |
| Aug 6, 2026SCHEDULE 13G | Other filings |
| Aug 3, 2026144 | Notice of proposed sale (Form 144) |
| Jul 28, 20264 | Insider transaction (Form 4) |
| Jul 27, 2026144 | Notice of proposed sale (Form 144) |
| Jul 6, 20264 | Insider transaction (Form 4) |
| Jun 29, 202611-K | Employee plan annual report |
| Jun 29, 202611-K | Employee plan annual report |
| Jun 26, 20264 | Insider transaction (Form 4) |
| Jun 26, 2026144 | Notice of proposed sale (Form 144) |
| Jun 25, 20264 | Insider transaction (Form 4) |
| Jun 24, 2026144 | Notice of proposed sale (Form 144) |
The newest 25 of 89 shown; the full year is on EDGAR.
2025 · 103 filings — 60 × 4, 19 × 144, 7 × 3 and 9 other forms
| Filed | What it is |
|---|---|
| Dec 31, 20253 | Initial insider holdings (Form 3) |
| Dec 29, 2025144 | Notice of proposed sale (Form 144) |
| Dec 29, 20254 | Insider transaction (Form 4) |
| Dec 17, 20254 | Insider transaction (Form 4) |
| Dec 17, 2025144 | Notice of proposed sale (Form 144) |
| Dec 11, 20253 | Initial insider holdings (Form 3) |
| Dec 3, 2025EFFECT | Other filings |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20253 | Initial insider holdings (Form 3) |
| Dec 2, 20253 | Initial insider holdings (Form 3) |
| Dec 1, 2025144 | Notice of proposed sale (Form 144) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Nov 25, 2025POS AM | Registration and prospectus |
The newest 25 of 103 shown; the full year is on EDGAR.
2024 · 93 filings — 49 × 4, 11 × 144, 10 × 424B2 and 9 other forms
| Filed | What it is |
|---|---|
| Dec 20, 20244 | Insider transaction (Form 4) |
| Dec 19, 2024144 | Notice of proposed sale (Form 144) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Dec 9, 2024144 | Notice of proposed sale (Form 144) |
| Dec 6, 20244 | Insider transaction (Form 4) |
| Dec 6, 2024144 | Notice of proposed sale (Form 144) |
| Dec 6, 2024144 | Notice of proposed sale (Form 144) |
| Dec 5, 2024144 | Notice of proposed sale (Form 144) |
| Dec 3, 20244/A | Insider transaction (Form 4), amended |
| Dec 3, 20244/A | Insider transaction (Form 4), amended |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 29, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Sep 16, 2024144 | Notice of proposed sale (Form 144) |
The newest 25 of 93 shown; the full year is on EDGAR.
2023 · 86 filings — 50 × 4, 9 × 144, 4 × 25-NSE and 11 other forms
Counted, not listed; the year is on EDGAR.
2022 · 78 filings — 54 × 4, 7 × 3, 3 × 11-K and 11 other forms
Counted, not listed; the year is on EDGAR.
2021 · 88 filings — 57 × 4, 8 × 424B2, 4 × FWP and 9 other forms
Counted, not listed; the year is on EDGAR.
2020 · 82 filings — 59 × 4, 5 × 424B2, 5 × SC 13G/A and 9 other forms
Counted, not listed; the year is on EDGAR.
2019 · 91 filings — 74 × 4, 3 × SC 13G/A, 2 × 3 and 11 other forms
Counted, not listed; the year is on EDGAR.
2018 · 113 filings — 75 × 4, 10 × 3, 8 × 424B2 and 14 other forms
Counted, not listed; the year is on EDGAR.
2017 · 98 filings — 49 × 4, 10 × 425, 9 × 424B2 and 17 other forms
Counted, not listed; the year is on EDGAR.
2016 · 76 filings — 64 × 4, 2 × 3, 2 × 424B5 and 7 other forms
Counted, not listed; the year is on EDGAR.
2015 · 110 filings — 87 × 4, 5 × CORRESP, 4 × 425 and 12 other forms
Counted, not listed; the year is on EDGAR.
2014 · 102 filings — 66 × 4, 17 × 425, 5 × 3 and 12 other forms
Counted, not listed; the year is on EDGAR.
2013 · 85 filings — 74 × 4, 5 × 3, 1 × 11-K and 5 other forms
Counted, not listed; the year is on EDGAR.
2012 · 74 filings — 60 × 4, 3 × 3, 3 × UPLOAD and 7 other forms
Counted, not listed; the year is on EDGAR.
2011 · 80 filings — 69 × 4, 3 × 3, 2 × 424B2 and 5 other forms
Counted, not listed; the year is on EDGAR.
2010 · 100 filings — 85 × 4, 2 × 424B2, 2 × 5 and 9 other forms
Counted, not listed; the year is on EDGAR.
2009 · 85 filings — 68 × 4, 2 × 3, 2 × 424B2 and 9 other forms
Counted, not listed; the year is on EDGAR.
2008 · 111 filings — 95 × 4, 3 × CORRESP, 3 × UPLOAD and 7 other forms
Counted, not listed; the year is on EDGAR.
2007 · 101 filings — 85 × 4, 3 × 3, 3 × 4/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2006 · 118 filings — 97 × 4, 5 × 3, 4 × SC 13D/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2005 · 103 filings — 88 × 4, 3 × 4/A, 3 × SC 13G/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2004 · 186 filings — 174 × 4, 4 × SC 13G/A, 3 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2003 · 108 filings — 97 × 4, 5 × SC 13G/A, 2 × SC 13G and 4 other forms
Counted, not listed; the year is on EDGAR.
2002 · 5 filings — 2 × SC 13G, 2 × SC 13G/A, 1 × 11-K
Counted, not listed; the year is on EDGAR.
2001 · 9 filings — 4 × SC 13G/A, 3 × SC 13G, 1 × 11-K and 1 other form
Counted, not listed; the year is on EDGAR.
2000 · 8 filings — 3 × SC 13G/A, 2 × 8-A12B/A, 2 × SC 13G and 1 other form
Counted, not listed; the year is on EDGAR.
1999 · 9 filings — 5 × SC 13G/A, 2 × SC 13G, 1 × 11-K and 1 other form
Counted, not listed; the year is on EDGAR.
1998 · 8 filings — 3 × SC 13G, 2 × SC 13G/A, 1 × 11-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1997 · 9 filings — 3 × SC 13G/A, 2 × S-3, 2 × SC 13G and 2 other forms
Counted, not listed; the year is on EDGAR.
1996 · 8 filings — 3 × SC 13G/A, 2 × S-8, 1 × 15-12G and 2 other forms
Counted, not listed; the year is on EDGAR.
1995 · 7 filings — 4 × SC 13G/A, 2 × S-8, 1 × 424B5
Counted, not listed; the year is on EDGAR.
1994 · 4 filings — 2 × SC 13G, 1 × 11-K, 1 × S-8
Counted, not listed; the year is on EDGAR.
About this data#
Becton Dickinson and Company (BDX) has 3,060 filings on EDGAR going back to 1994: 35 annual reports, 100 quarterly reports and 427 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Nov 25, 2025 for the fiscal year ended Sep 30, 2025. The most recent 8-K, on Aug 6, 2026, covered results of operations. Over the last 13 months insiders sold $2.6M in 16 sales and bought nothing on the open market; 39 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Becton Dickinson and Company, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read BDX's latest 10-K?
- BDX's latest annual report, a 10-K, was filed on Nov 25, 2025 for the fiscal year ended Sep 30, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did BDX last file an 8-K?
- On Aug 6, 2026 it covered results of operations. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.
- Are BDX insiders buying or selling?
- Over the last 13 months insiders sold $2.6M in 16 sales and bought nothing on the open market; 39 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Feld Michael (EVP, Chief Revenue Officer) sold 76 shares on Sep 28, 2026 for $14K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has BDX made?
- 3,060 filings are on EDGAR under the registrant records that have been Becton Dickinson and Company, going back to 1994; 1,962 of them are insider ownership forms (Forms 3, 4, 5 and 144).